Procainamide Hydrochloride Injection, Solution
Product Images NDC 68083-603

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 68083-603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Procainamide-spl-container-label-100mg (Procainamide Spl Container Label 100mg)

Label for Procainamide Hydrochloride Injection, USP, 1 gram/10 mL (100 mg/mL) in a 10 mL multiple-dose vial. The label states active ingredients including Procainamide Hydrochloride 100 mg per mL and preservatives, with storage instructions and warnings about metabisulfites. Manufactured by Gland Pharma Limited, Hyderabad, India.*

FDA Label Image

Procainamide-spl-container-label-500mg (Procainamide Spl Container Label 500mg)

Label for Procainamide Hydrochloride Injection, USP 500 mg/mL in a 2 mL multiple-dose vial, containing 1 gram per 2 mL. Manufactured by Gland Pharma Limited, Hyderabad, India. The label includes usage warnings about metabisulfites and storage instructions at 20°C to 25°C (68°F to 77°F). The label also lists preservatives and pH adjusters information.*

FDA Label Image

Procainamide-spl-inner-carton-label-100mg (Procainamide Spl Inner Carton Label 100mg)

Packaging label for Procainamide Hydrochloride Injection, USP 1 gram/10 mL (100 mg/mL) solution for intramuscular or intravenous use. The label states the product is Rx only and comes in a 10 mL multiple-dose vial. It includes warnings about containing metabisulfites and storage conditions. The labeler is Gland Pharma Limited, Hyderabad, India, with NDC 68083-603-01.*

FDA Label Image

Procainamide-spl-outer-carton-label-100mg (Procainamide Spl Outer Carton Label 100mg)

Packaging label for Procainamide Hydrochloride Injection, USP 1 gram/10 mL (100 mg/mL) by Gland Pharma Limited. The label indicates multiple-dose vials, 25 vials of 10 mL each. It includes warnings for metabissulfites, directions for aseptic technique, and storage instructions at controlled room temperature. The manufacturer information and barcode are also visible.*

FDA Label Image

Procainamide-spl-outer-carton-label-500mg (Procainamide Spl Outer Carton Label 500mg)

Packaging label for Procainamide Hydrochloride Injection, USP 1 gram/2 mL (500 mg/mL). The label indicates the product contains metasulfites and is presented in 25 vials of 2 mL each, multiple-dose vials. Manufactured by Gland Pharma Limited, with NDC 68083-604-25. The label includes dosage warnings, storage instructions, and barcode.*

FDA Label Image

Procainamide-spl-structure (Procainamide Spl Structure)

Chemical structure diagram of Procainamide Hydrochloride showing its molecular formula and associated hydrochloride (HCl) component, with a molecular weight of 271.79.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.